Pacific Biosciences of California, Inc. (PACB)
Nasdaq · Common stock · Laboratory Analytical Instruments
As of Oct 21, 3:20 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow PACB in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on PACB and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
PACB at a glance
Key statistics
$609.23M
Market capitalization
- Previous close
- $1.96
- Open
- $1.98
- Day range
- $1.93 – $2.19
- Volume
- 9.68M
- Average volume (30 sessions)
- 15.53M
- Shares outstanding
- 310.83M
- Earnings per share
- $(0.42)
- Price / sales
- 3.8
- Beta (1 year, vs SPY)
- 2.34
Where the price sits in its year
52-week range
45% of the range
- Below the 52-week high
- -38.1%
- Above the 52-week low
- +98.6%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $2.11-6.9%
- 50-day average
- $1.63+20.1%
- 200-day average
- $1.60+22.8%
Between the conventional 30 and 70 bands.
-4.4%
1 week
+44.1%
1 month
+42.0%
3 months
+4.8%
Year to date
+19.5%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with PACB
PACB on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on PACB.
See the plans →
Every planScreen names like PACB
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on PACB
Put PACB on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on PACB
See whether there is an open premium alert on PACB, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
PACB headlines
- Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Benzinga · Jun 3, 2024
- Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts
Benzinga · May 13, 2024
- A Glimpse Into The Expert Outlook On Pacific Biosciences Through 4 Analysts
Benzinga · Apr 17, 2024
SEC Form 4, most recent first
Insider filings
Gibson James R II
−500.0K
See Remarks · Option exercise
· Oct 6, 2026
Gibson James R II
−661.8K
See Remarks · Open-market sale
$2.06M · Oct 6, 2026
Gibson James R II
+500.0K
See Remarks · Option exercise
$590.00K · Oct 6, 2026
Van Oene Mark
−26.9K
See Remarks · Open-market sale
$30.41K · Aug 17, 2026
Van Oene Mark
+1.97M
See Remarks · Grant or award
· Aug 10, 2026
Van Oene Mark
+489.1K
See Remarks · Grant or award
· Aug 10, 2026
LIVINGSTON RANDALL S
+223.5K
Director · Grant or award
· Jun 3, 2026
MILLIGAN JOHN F
+223.5K
Director · Grant or award
· Jun 3, 2026
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Menlo Park, CA
- Employees
- 485
- Listed since
- Oct 27, 2010
- Website
- pacb.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.